Alpha Cognition (ACOG) Income from Continuing Operations (2023 - 2025)
Alpha Cognition's (ACOG) quarterly Income from Continuing Operations came in at 7998182.0 in Q4 2025, down 225.08% year-on-year from 6394402.85 in Q4 2024, and down 706.81% quarter-over-quarter from 1318074.0 in Q3 2025.
Alpha Cognition (ACOG) Income from Continuing Operations (2023 - 2025) Analysis & Trends
Alpha Cognition's Income from Continuing Operations history runs 3 years deep, the most recent figure standing at 7998182.0 for Q4 2025.
- On a quarterly basis, Income from Continuing Operations fell 225.08% year-over-year to 7998182.0 in Q4 2025; TTM through Dec 2025 was 21885879.0, a 91.34% decrease from a year earlier, with the FY2025 full-year figure at 42551689.0, down 51.69% from the prior year.
- Income from Continuing Operations eased to 7998182.0 in Q4 2025 per ACOG's latest filing, from 1318074.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 1318074.0 in Q3 2025 and bottomed at 13199228.0 in Q2 2025.
- The 3-year median for Income from Continuing Operations is 2460366.0 (2024), against an average of 3750947.27.
- Biggest YoY gain for Income from Continuing Operations was 170.87% in 2025; the steepest drop was 523.93% in 2025.
- Year by year, Income from Continuing Operations stood at 2435822.0 in 2023, then decreased by 1.01% to 2460366.0 in 2024, then plunged by 225.08% to 7998182.0 in 2025.
- Per Business Quant, the three latest ACOG Income from Continuing Operations figures stand at 7998182.0 (Q4 2025), 1318074.0 (Q3 2025), and 13199228.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -37.09 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.68 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 727.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Alpha Cognition | 145.51 Mn | 79.41 Mn | 2.61 Mn | -8.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -8.00 Mn |
| Sep 30, 2025 | 1.32 Mn |
| Jun 30, 2025 | -13.20 Mn |
| Mar 31, 2025 | -2.01 Mn |
| Dec 31, 2024 | -2.46 Mn |
| Sep 30, 2024 | -1.86 Mn |
| Jun 30, 2024 | -2.12 Mn |
| Mar 31, 2024 | -5.00 Mn |
| Dec 31, 2023 | -2.44 Mn |
| Sep 30, 2023 | -2.77 Mn |
| Jun 30, 2023 | -2.73 Mn |